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In this study we searched for the presence of human 
immunodeficiency virus (lllV-l)-spliced mRNA in 
epidermal cells from AIDS patients. Using reverse 
polymerase chain reaction and Southern hybridization 
we detected mRNA for HIV-l regulatory (tat, rev, neJ) 
and structural genes (env) in epidermal cells highly 
enriched for Langerhans cells, but not in Langerhans 
cell-depleted epidermal cells in two of three HIV-l-
infected patients tested. In contrast to the expression of 
mv-l mRNA, T-cell-specific mRNA was readily de-
tectable in all preparations of Langer hans cell-depleted 
T he human immunodeficiency virus type 1 (HIV-l), the causative agent of AIDS [1,2]' may infect a variety of cell types, including CD4+ T cells, brain cells, and antigen-presenting cells (for review see [3]) . In the latter context, conflicting reports exist concerning the 
involvement of bone-marrow - derived dendritic cells. Whereas 
certain investigators feel these cells are an important biologic target 
of HI V-I [4 - 6), others have reported that dendritic cells cannot be 
easily infected by HIV -1 and that the association of the virus with 
the dendritic cells has no deleterious consequences for the function 
of the antigen-presenting cells [7,8). Epidermal Langerhans cells are 
members of the dendritic cell family both from a phenotypic and 
functional viewpoint [9). Their involvement in the pathogenesis of 
AIDS was first suggested in 1984 by Belsito and co-workers, who 
found that Langerhans cell numbers are decreased in AIDS patients 
[10), a finding that was later called into question by data from other 
researchers [11] . By screening serial sections of skin from HIV -1 -
infected patients for the expression of HIV-l proteins, we have 
demonstrated the presence of viral gag proteins in resident Langer-
hans ceJls of certain patients [1 2] and have detected viral particles 
budding from their membrane [13). Although certain other investi-
gators have fai led to detect HIV -1 proteins or nucleic acids in epi-
dermal Langerhans cells [11,14), Zambruno and co-workers re-
cently demonstrated HIV-1 proviral DNA in Langerhans 
cell-enriched, but not in Langerhans cell-depleted, epidermal cells 
of seven of nine HIV-1-infected patients [15). Furthermore, using 
reverse transcriptase polymerase chain reaction (PCR), Kanitakis et 
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but in only one preparation of Langerhans cell-
enriched epidermal cells. This indicates that contami-
nating T cells are a very unlikely source of virus-speci-
fic mRNA in our epidermal cell preparations. Our 
data suggest that Langerhans cells are the main, if not 
the only, cell type infected with lllV-l within the epi-
dermis of AIDS patients and demonstrate that HIV-l 
regulatory as well as structural genes are transcribed in 
these cells. Key words: virus/spliced mRNA/skin/dendritic 
cells.] Invest Dermatol103:593-596, 1994 
al found HIV-1 mRNA in the epidermis of one of 12 patients [16) 
and Giannetti et al detected HIV-1 tat mRNA in Langerhans cell-
enriched epidermal cell preparations in six of nine patients [17). 
In an attempt to clarify this controversial issue of LC-infection by 
HIV, we studied the expression of mRNA for viral regulatory (tat, 
reI', nef) and structural (etlv) proteins by highly enriched Langerhans 
cells from HIV -1-seropositive patients. 
MATERIALS AND METHODS 
Skin Specimens and Preparation of Epidermal Cell Suspension For 
all experiments skin from deceased patients was used. All three HIV -1 -
seropositive patients were diagnosed as having AIDS at the time of their 
death and their last count of CD4+ T cells was < 50 cellS/ILl. Split-skin 
samples were obtained with disposable dermatomes (Davol/Simon Derma-
tome Cutting Heads No. 3295, Davollnc., Subsidary of Bard, Inc., Cran-
ston, R1) from clinically normal-appearing skin of both thighs. Following a 
30-min dispase (Dispase II; Boehringer Mannheim, Germany) incubation at 
37' C, the epidermis was peeled from the dermis and incubated for 15 min in 
1 % trypsin phosphate-buffered saline (PBS) (DIFCO Laboratories, Detroit, 
MI) at 37'C. Fetal bovine serum (FCS, GIBCO Laboratories, Paisley, Scot-
land) and 0.025% DNAse (Deoxyribonuclease I; Type TV; Sigma Chemical 
Co., St. Louis, MO) were added and the epidermal sheet was then gently 
vortexed for 15 seconds to produce an epidermal single cell suspension. 
Enrichment of Langerhans Cells The epidermal cell suspension was 
enriched for Langerhans cells according to a protocol published by M. Teun-
issen et al [18], with slight modilications. Briefly, 20 mI of epidermal cell 
suspension were layered over 20 ml of Ficoll-Paque (Pharmacia LKB Bio-
technology, Piscataway, NJ) that had been adjusted to a density of 1.068 
with PBS without Ca++ and Mg++. Density gradient centrifugation was 
performed at 4000 rpm (3400 gm,.) for 30 min at room temperature. A 
linear acce leration program of 100 seconds and a linear braking program of 
5 min was applied. Interface cells were collected and incubated with anti-
COla monoclonal antibody (OKT6, Ortho Diagnostic Systems 1I1C. Rari-
tan, NJ) at a dilution of 1 : 20 for 20 min on ice. After three washes, the cells 
were incubated with sheep-anti-mouse immunoglobulin (Ig)G1 magnetic 
beads (Deutsche Dynal GmbH, Hamburg, Germany) at 5-10 beads/cells 
for 40 min at 4· C under constant rotation. Separation of the bead-bound 
cells was carried out in 4-ml Falcon polystyrene, round-bottom tubes (Fal-
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Figure L The structure of genomic and singly (env) 
and doubly (tat, ,ell, nef) spliced H1V-l mRNAs. 
Primers used for the amplification of HIV -1- specific 
cDNA sequences are shown with their positions within 
the HIV -1 genome: US, universal HIV -1 5' primer; 
ART2, 3' primer for the amplification of envelope 
mRNA; ART7, 3' primer for the amplification of mRNAs 
of HIV -1 regulatory genes. The oligonucleotide probes 
S 1, S2, and S3 [19] were used to detect amplification prod-











con 2058, Becton Dickinson, Lincoln Park, NJ) between two magnetic 
plates for 5 min. The magnet-bound rosetted Langerhans cells were rinsed 
several times with PBS to completely remove all non - bead-bound cells and 
then pelleted for extraction of RNA. The remaining cell suspension was 
cleared for residual beads by an additional 30-min magnetic separation. In 
this manner, two fractions were obtained: an epidermal cell population 
enriched for Langerhans cells, which wi ll be referred to as EC(LC+), and 
epidermal cells depleted of Langerhans cells, which will be referred to as 
EC(LC- ). Staining of epidermal cell preparations for contaminating T cells 
was performed with a fluorescein isothiocyanate (FITC}-labeled mouse 
anti~CD3 monoclonal antibody (Leu-4, Becton Dickinson, San Jose, CAl. 
Extraction of RNA and Reverse Transcriptase PCR RNA was ex-
tracted from EC(LC+) and EC(LC- ) by RNAzol (CINNA/Biotecx Lab. 
Inc., TX) according to the procedure recommended by the supplier. Because 
the amount of RNA obtained from the different cell preparations was too 
low to be measured by ultraviolet (UV) absorption spectrophotometry, ali-
quots of each RNA preparation derived from EC(LC+) and EC(LC-) were 
electrophoresed through a 1 % agarose gel and stained with ethidium bro-
mide. EC(LC+)- and EC(LC- )-derived RNA was adjusted to equivalent 
concentrations according to the ethidium bromide picture and equal 
amounts of RNA were nsed for reverse transcription. RNA was reverse 
transcribed to cDNA using oligo dT as a primer and 300 U superSCRIPT 
RNAse H- reverse transcriptase (GIBCO-BRL, Gaitherburg, MD) in 20 jll 
reaction mixture. Five microliters of the resulting cDNA template was used 
for each PCR assay. 
For amplification of defined pieces ofHIV-1-spliced mRNA, two primer 
pairs [19] were selected (Fig 1), the primer combination US/ Art7 for HIV-1 
regulatory genes (tat, rev, Ilef) and the combination US/ Art2 for ellv mRNA. 
T he reaction mixture was denatured at 94 ° C for 30 seconds, annealed at 
55°C for 30 seconds, and extended at 72°C for 2 min; the samples were 
amplified through 35 cycles. The PCR products were electrophoresed 
through 2% agarose gels and transferred onto Nytran membranes 
(Schleicher & Schuell, Dassel, Germany). Membranes were hybridized with 
32P-labeled oligonucleotide probes S 1, S2, S3, which were designed to detect 
PCR products specific for the different HIV -1 mRNA species, as outlined in 
Fig 1. 
For detection of the delta chain of the CD3 molecule [20], equal amounts 





•••••••••••••• _ envelope mANA 
-::::::::::::::: envelope mANA 
_ envelope mANA 
o iii C!) tat mANA 
o I:l!I!I • rev mANA 
o l!lII • nefmANA 
I Oligonucleotide hybridization probes used lor identilication 01: 
51 (5414 -M38) ---""-.,-----.. lal 
-
~(5536' 5559' ----'\----il~ tat. rev 
.. 
S3 (5567 ,55BO, ---,"--- lat. rev. nef. env 
• 
including denaturation of 94°C for 30 seconds, annealing at 55°C for 
30 seconds, and extension of the primer at 72°C for 2 min. PCR primers for 
the CD3§ chain were designed to amplify a 444-bp product (sense T3; 
5' -ATG GAA CAT AGC ACG TTT CTC-3'; antisense T5, 5' -GAC CTG 
GTC ATT CCT CAA CAG-3'). For detection by Southern hybridization of 
the PCR products, a 32P-labe1ed internal oligonucleotide was used (T4, 
5'-TTG TGT GTC GGC AGC CCC AGA CAG CCT-3'). 
RESULTS 
Enrichment of Langerhans cells was performed by gradient centrif-
ugation and m agnetic bead separation and consistently yielded more 
than 90% rosetted CD1a+ cells. eDNA derived from EC(LC+) or 
EC(LC-) was subjected to PCR using the primer pair US/ Art7, as 
specified in Materials arId Methods. Specific amplification products 
(=219/225 bp) ofHIV-l rev were readily detected in EC(LC+) of 
two of three AIDS patients (Fig 2B, lanes Z, 4, and 6) but not in 
EC(LC-) (Fig 2B, lanes 1, 3, and 5). HIV-l tat (402 bp) was de-
tected only in EC(LC+) of one of the three patients tested (Fig 2A, 
lane 6). The weak signal at = 220 bp in lanes 4 and 6 of panel A (Fig 
2) is due to incomplete stripping of probe S2 before rehybridization 
with probe S 1. Despite the small size difference between the HIV-1 
nif and rev amplification products the former is clearly detectable in 
Langerhans cells of one of the patients analyzed (= 203 bp, Fig 2C, 
lane 4). HIV -1 env mRNA amplification products of = 466 bp were 
detected in the samples that were also positive for mRNA of viral 
regulatory genes (Fig 2D, lanes 4 and 6). Again, EC(LC-) were 
clearly negative for any expression of nif and etlV mRNA. When 
EC(LC+) or EC(LC- ) of an HIV -1-seronegative patient were ana-
lyzed under the same conditions, no specific amplification products 
could be detected (data not shown). 
By conventional immunostaining CD3+ cells were detectable 
neither in the starting epidermal cell population nor in any of the 
Langerhans cell-enriched or -depleted fractions. In contrast, CD3t5-
specific mRNA was clearly present in all three EC(LC- ) prepara-
tions (Fig 3, lanes 1, 3, and 5) bllt only in one of the three 
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Figure 2. Detection ofmY-1-spliced mRNA in epidermal cell preparations of AIDS patients. After amplification of defined fragments ofHIV-t 
mRNA by reverse PCR (primers US/ ART7 for A, B, C and primers US/ ART2 for D), the amplification products were electrophoresed through a 2% agarose 
gel, transferred onto nylon membranes, and hybridized sequentially to the oligonucleotide probes described in Fig 1 in the following order: A) probe S1; B) 
probe S2; C) probe S3. Probe S3 was also used for hybridization in (D). Latles 1,3, mId 5 of all panels contain PCR products derived from EC(LC-) , lanes 2,4, and 
6 from EC(LC+), lane 7 is empty, lane 8 contains the negative control (no eDNA template), and lane 9 contains the positive control (RNA from an 
HIV-1-infected B-celiline). 
EC(LC+) preparations was a discernable band detectable (Fig 3, 
lane 6) . 
DISCUSSION 
To address the issue of productive infection of epidermal Langer-
hans cells in the course of HIV -1 disease we searched for expression 
of viral mRNA in Langerhans cells derived from AIDS patients. 
Through reverse transcriptase PCR, we found expression of singly 
and doubly spliced mRNA of viral regulatory and structural genes 
in Langerhans cell-enriched but not Langerhans cell-depleted epi-
dermal cells in two of three patients. 
To rule out the possibility that contaminating T lymphocytes 
infected with HIV -1 were the source of viral mRNA in our prepara-
tions, we performed reverse transcriptase PCR for the CD315 chain 
on the various samples of epidermal cell-derived cDNAs. Whereas 
with conventional immunofluorescence we detected virtually no T 
cells in any of our epidermal cell populations, the detection by PCR 
of CD315 transcripts indicates that these cells were present. How-
pat. 1 pat.2 pat.3 






Figure 3. Detection of the t5 chain of the CD3 receptor in EC(LC-) 
and EC(LC+). The same cDNA preparation used in Fig 2 to amplify 
HIV-t mRNA fragments was subjected to PCR using the primers T3/TS. 
After amplification and Southern blotting of the amplified fragments, the 
filters were hybridized to oligonucleotide probe T4 to detect CD3t5-specific 
sequences. Lanes 1,3, alld 5 contain PCR products derived from EC(LC-), 
lanes 2, 4, alld 6 from EC (LC+), lalle 7 contains the negative control (no 
cDNA template), and lalle 8 contains the positive control (RNA derived 
from peripheral blood mononuclear cells). 
ever, the identification of HIV-1 mRNA exclusively in EC(LC+) 
and the presence of T-cell-specific mRNA preferentially in 
EC(LC-) practically excludes T cells as a source of the HIV-l 
mRNA in our experiments. Apart from the remote possibility that 
HIV-l-infected monocytes contaminated the EC(LC+) but not 
EC(LC-) fraction, our data strongly suggest that HIV-l regulatory 
and structural genes are actively transcribed in epidermal Langer-
hans cells ofHIV-l- infected patients. We, therefore, conclude that 
Langerhans cells are an actual target for productive HIV-l infection 
itl vivo, and that Langerhans cells are the main, if not the only, celI 
type within the epidermis infected by HIV-l. 
With regard to expression of the different viral mRNA species, 
we found that in one of the patients HIV-l tat was not expressed. 
although rev, 111, and env amplification products were present. This 
finding is puzzling because HIV-l gene expression is dependent on 
transactivation of the viral LTR by the tat gene product [3]. An 
explanation for this phenomenon would be the translation of the 
HIV-1 tat protein from an alternative mRNA species that escaped 
detection by our PCR protocol. Indeed. the presence of a single 
spliced tat mRNA too big for amplification with our PCR primers 
has been described by Cullen et af [21] in cells transfected with 
HIV-1 proviral DNA it! vitro. However, the existence of this 
mRNA species ill vivo has not been demonstrated so far. The possi-
bility that we failed to detect HIV -1 tat because of its lower level of 
expression as compared to rei! and 11 if [22]. is negligible because even 
after prolonged exposure of the Southern blots we were unable to 
detect an according amplification product (data not shown). An 
alternative explanation for the fact that HIV -1 was transcriptionally 
active in the absence of tat in this particular patient may be that 
factors other than lat can activate the HIV -1 promoter in La.nger-
hans cells. Perhaps celIular transcription factors either endoge-
nously present in Langerhans cells or exogenously activated by sol-
uble mediators. e.g.. tumor necrosis factor [23.24]. from 
surrounding keratinocytes, as well as the presence of other viruses 
(e.g .• human herpes viruses [25]) could substitute for the effect of tat 
on the viral L TR. 
To elucidate the mechanisms that govern HIV -1 expression in 
Langerhans cells. ill lJitro infection of these cells and analysis of 
biologic and molecular consequences of HI V -1 transcription will be 
necessary. Such studies have so far been hampered by limitations 
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encountered in Langerhans cell purification from epidermal cell 
samples and their in vitro culture. With new culture techniques 
available [26,27], it should now be possible to address questions 
regarding HIV -1 cytopathicity on Langerhans cells and the effect of 
HIV -1 infection on phenotype and function of these cells and their 
cutaneous symbionts. 
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